Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Leukemia
|
September 23, 2006
FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248)
M M Schittenhelm, K W H Yee, J W Tyner, et al.
Blood
|
August 1, 1997
Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells
R K Rathbun, G R Faulkner, M H Ostroski, et al.
Blood
|
February 7, 1998
DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function
M C Heinrich, M E Hoatlin, A J Zigler, et al.
Leukemia
|
November 6, 2009
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells
U Rix, L L Remsing Rix, A S Terker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2016
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
E Ben-Ami, C M Barysauskas, M von Mehren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2023
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib
C Serrano, S Bauer, D Gómez-Peregrina, et al.
Medical Oncology (Northwood, London, England)
|
September 29, 2011
Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs
J F Emile, S Brahimi, J M Coindre, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Leukemia
|
September 23, 2006
FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248)
M M Schittenhelm, K W H Yee, J W Tyner, et al.
Blood
|
August 1, 1997
Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells
R K Rathbun, G R Faulkner, M H Ostroski, et al.
Blood
|
February 7, 1998
DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function
M C Heinrich, M E Hoatlin, A J Zigler, et al.
Leukemia
|
November 6, 2009
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells
U Rix, L L Remsing Rix, A S Terker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2016
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
E Ben-Ami, C M Barysauskas, M von Mehren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2023
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib
C Serrano, S Bauer, D Gómez-Peregrina, et al.
Medical Oncology (Northwood, London, England)
|
September 29, 2011
Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs
J F Emile, S Brahimi, J M Coindre, et al.
Page
of 5